AlphaMark Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $261K | Buy |
1,002
+32
| +3% | +$9.49K | 0.11% | 110 |
|
|
2024
Q3 | $313K | Sell |
970
-106
| -10% | -$34.7K | 0.11% | 184 |
|
|
2024
Q2 | $336K | Buy |
1,076
+1
| +0.1% | +$294 | 0.12% | 121 |
|
|
2024
Q1 | $306K | Buy |
1,075
+2
| +0.2% | +$585 | 0.11% | 155 |
|
|
2023
Q4 | $309K | Buy |
1,073
+28
| +3% | +$7.63K | 0.12% | 128 |
|
|
2023
Q3 | $281K | Sell |
1,045
-78
| -7% | -$19.5K | 0.12% | 109 |
|
|
2023
Q2 | $249K | Buy |
1,123
+2
| +0.2% | +$464 | 0.11% | 99 |
|
|
2023
Q1 | $271K | Buy |
1,121
+3
| +0.3% | +$736 | 0.12% | 91 |
|
|
2022
Q4 | $294K | Buy |
1,118
+1
| +0.1% | +$268 | 0.15% | 78 |
|
|
2022
Q3 | $252K | Buy |
1,117
+40
| +4% | +$9.7K | 0.12% | 88 |
|
|
2022
Q2 | $262K | Buy |
1,077
+2
| +0.2% | +$490 | 0.12% | 94 |
|
|
2022
Q1 | $260K | Buy |
1,075
+2
| +0.2% | +$460 | 0.1% | 108 |
|
|
2021
Q4 | $241K | Sell |
1,073
-132
| -11% | -$27.9K | 0.08% | 118 |
|
|
2021
Q3 | $256K | Sell |
1,205
-8
| -0.7% | -$1.84K | 0.09% | 110 |
|
|
2021
Q2 | $296K | Buy |
1,213
+2
| +0.2% | +$492 | 0.11% | 104 |
|
|
2021
Q1 | $301K | Buy |
1,211
+2
| +0.2% | +$477 | 0.11% | 101 |
|
|
2020
Q4 | $278K | Buy |
1,209
+11
| +0.9% | +$2.54K | 0.11% | 96 |
|
|
2020
Q3 | $304K | Sell |
1,198
-4
| -0.3% | -$991 | 0.13% | 77 |
|
|
2020
Q2 | $283K | Buy |
1,202
+30
| +3% | +$6.84K | 0.12% | 74 |
|
|
2020
Q1 | $238K | Buy |
1,172
+52
| +5% | +$11.4K | 0.13% | 73 |
|
|
2019
Q4 | $270K | Buy |
1,120
+50
| +5% | +$11K | 0.11% | 86 |
|
|
2019
Q3 | $207K | Sell |
1,070
-100
| -9% | -$19.2K | 0.09% | 97 |
|
|
2019
Q2 | $216K | Sell |
1,170
-255
| -18% | -$45.7K | 0.09% | 91 |
|
|
2019
Q1 | $271K | Sell |
1,425
-23,077
| -94% | -$4.41M | 0.11% | 77 |
|
|
2018
Q4 | $4.77M | Sell |
24,502
-3,330
| -12% | -$650K | 2.29% | 7 |
|
|
2018
Q3 | $5.77M | Sell |
27,832
-412
| -1% | -$81.2K | 2.32% | 4 |
|
|
2018
Q2 | $5.21M | Buy |
28,244
+271
| +1% | +$47.9K | 2.11% | 5 |
|
|
2018
Q1 | $4.77M | Sell |
27,973
-1,638
| -6% | -$301K | 2.04% | 7 |
|
|
2017
Q4 | $5.15M | Buy |
29,611
+91
| +0.3% | +$16.1K | 2.01% | 9 |
|
|
2017
Q3 | $5.5M | Sell |
29,520
-1,235
| -4% | -$219K | 2.33% | 6 |
|
|
2017
Q2 | $5.3M | Buy |
30,755
+1,245
| +4% | +$202K | 2.27% | 5 |
|
|
2017
Q1 | $4.84M | Buy |
29,510
+146
| +0.5% | +$24.3K | 2.25% | 4 |
|
|
2016
Q4 | $4.29M | Sell |
29,364
-363
| -1% | -$54.6K | 2.22% | 6 |
|
|
2016
Q3 | $4.96M | Sell |
29,727
-361
| -1% | -$61K | 2.5% | 5 |
|
|
2016
Q2 | $4.58M | Sell |
30,088
-55
| -0.2% | -$8.55K | 2.7% | 5 |
|
|
2016
Q1 | $4.52M | Sell |
30,143
-1,923
| -6% | -$286K | 2.4% | 4 |
|
|
2015
Q4 | $5.21M | Sell |
32,066
-123
| -0.4% | -$19.3K | 2.65% | 2 |
|
|
2015
Q3 | $4.45M | Sell |
32,189
-513
| -2% | -$80.9K | 2.48% | 6 |
|
|
2015
Q2 | $5.02M | Sell |
32,702
-29
| -0.1% | -$4.65K | 2.82% | 3 |
|
|
2015
Q1 | $5.23M | Sell |
32,731
-1,639
| -5% | -$258K | 2.93% | 3 |
|
|
2014
Q4 | $5.47M | Sell |
34,370
-2,648
| -7% | -$413K | 3.38% | 2 |
|
|
2014
Q3 | $5.2M | Sell |
37,018
-3,676
| -9% | -$480K | 3.28% | 2 |
|
|
2014
Q2 | $4.82M | Sell |
40,694
-209
| -0.5% | -$24.2K | 2.87% | 4 |
|
|
2014
Q1 | $5.04M | Sell |
40,903
-375
| -0.9% | -$45.5K | 3.1% | 2 |
|
|
2013
Q4 | $4.71M | Sell |
41,278
-1,942
| -4% | -$221K | 2.94% | 4 |
|
|
2013
Q3 | $4.84M | Sell |
43,220
-4,241
| -9% | -$460K | 3.06% | 2 |
|
|
2013
Q2 | $4.68M | Buy |
+47,461
| New | +$4.93M | 2.85% | 3 |
|
Other funds holding AMGN
AlphaMark Advisors's AMGN Position: Q4 2024 in Review
AlphaMark Advisors increased its Amgen (AMGN) stake by 3.3% in Q4 2024, buying an estimated $9.49K and bringing the position to 1,002 shares worth $261K. The position accounts for 0.11% of the portfolio, ranked #110.
AlphaMark Advisors first reported a position in AMGN in Q2 2013 and has held it in 47 quarters since. The position peaked at $5.77M in Q3 2018. 2,856 funds tracked by Wall St. Rank hold AMGN as of Q4 2024.
- AlphaMark Advisors held 1,002 shares of Amgen worth $261K as of Q4 2024.
- AlphaMark Advisors bought 32 Amgen shares in Q4 2024, an estimated $9.49K.
- Amgen made up 0.11% of AlphaMark Advisors's portfolio in Q4 2024, its #110 holding.
- AlphaMark Advisors first reported a position in Amgen in Q2 2013 and has held it in 47 quarters since.
- AlphaMark Advisors's Amgen position peaked at $5.77M in Q3 2018.
- 2,856 funds tracked by Wall St. Rank held Amgen as of Q4 2024.
Based on AlphaMark Advisors's 13F filing for Q4 2024, filed 21 Jan 2025.